Regulus Therapeutics
RGLS
#9245
Rank
S$0.10 B
Marketcap
$1.62
Share price
0.00%
Change (1 day)
-18.65%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -S$54.71 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$39.41 Million a decrease over its 2022 earnings that were of -S$37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$54.71 Million38.82%
2023 -S$39.41 Million6.51%
2022 -S$37 Million2.53%
2021 -S$36.09 Million93.59%
2020 -S$18.65 Million-15.41%
2019 -S$22.04 Million-64.46%
2018 -S$62 Million-33.26%
2017 -S$92.9 Million-13.98%
2016 -S$0.11 Billion44.77%
2015 -S$74.6 Million-1.63%
2014 -S$75.84 Million203.6%
2013 -S$24.98 Million8.65%
2012 -S$22.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$5.58 B-10,182.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$9.91 B-18,006.74%๐Ÿ‡ซ๐Ÿ‡ท France
S$2.55 B-4,707.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$12.91 B-23,409.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$0.26 Billion 351.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.18 Billion 224.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$9.22 Billion 16,530.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion 184.40%๐Ÿ‡บ๐Ÿ‡ธ USA